Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 30, 2017 at 12:15 PM EDT

Why Neos Therapeutics Is Holding Out Against PDL BioPharma

In a decisive move, the Neos Therapeutics board of directors unanimously struck down an acquisition proposal from PDL BioPharma.

Chris Lange | Oct 30, 2017 at 11:15 AM EDT

What to Expect When Pfizer Reports Earnings

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 30, 2017 at 10:40 AM EDT

Why Novartis Is Moving to Acquire Advanced Accelerator Applications

Advanced Accelerator Applications shares made a run early on Monday after it came public that Novartis plans to buy the…

Chris Lange | Oct 30, 2017 at 10:20 AM EDT

Endo International Wins Big on Preliminary Results

Endo International saw its shares make a solid gain to start off the week after the firm announced preliminary financial…

Chris Lange | Oct 28, 2017 at 10:05 AM EDT

Top Biopharma Events Coming by the End of 2017

24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November…

Chris Lange | Oct 28, 2017 at 8:40 AM EDT

Despite Poor Earnings Reaction, Analysts Still See Upside for Gilead

Out of all the biotechs that reported earnings last week, Gilead Sciences seems to be the one that hasn’t been…

Chris Lange | Oct 27, 2017 at 10:55 AM EDT

Why AbbVie Won Big in Q3, and Can Keep Winning

AbbVie reported better-than-expected third-quarter before the markets opened on Friday due to strong sales of Humira and Imbruvica.

Chris Lange | Oct 27, 2017 at 8:50 AM EDT

Merck Earnings Fall Short Despite Incredible Keytruda Sales

Pharma giant Merck reported mixed third-quarter financial results before the markets opened on Friday.

Jon C. Ogg | Oct 26, 2017 at 4:18 PM EDT

Gilead Earnings Bring Mixed Results

Gilead Corporation (NASDAQ: GILD) has joined other biotech giants in releasing its earnings for the third quarter of 2017. The…

Chris Lange | Oct 26, 2017 at 11:40 AM EDT

National Vision Enters the Market With a Bang

National Vision Holdings entered the market with a bang Thursday morning. The company priced its shares above the expected range.

Chris Lange | Oct 26, 2017 at 10:05 AM EDT

Why Celgene Sank to New Low Despite Q3 Earnings Beat

Despite mixed results, with earnings were fairly positive for the quarter, this was not enough to outweigh poor guidance. Shares…

Chris Lange | Oct 25, 2017 at 10:40 AM EDT

Short Sellers Chase Biotechs Higher

The October 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Oct 25, 2017 at 8:15 AM EDT

Jefferies Has Top Health Care Stocks to Buy as Sector Explodes

These are four top companies for more aggressive investors looking for health care exposure to consider.

Chris Lange | Oct 23, 2017 at 11:20 AM EDT

The Tale of 2 Biotechs: Aimmune vs DBV Tech

The tale of two biotechs appears to be playing out between Aimmune Therapeutics and DBV Technologies, not just for the…

1 … 151 152 153 154 155 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Neos Therapeutics Is Holding Out Against PDL BioPharma

What to Expect When Pfizer Reports Earnings

Why Novartis Is Moving to Acquire Advanced Accelerator Applications

Endo International Wins Big on Preliminary Results

Top Biopharma Events Coming by the End of 2017

Despite Poor Earnings Reaction, Analysts Still See Upside for Gilead

Why AbbVie Won Big in Q3, and Can Keep Winning

Merck Earnings Fall Short Despite Incredible Keytruda Sales

Gilead Earnings Bring Mixed Results

National Vision Enters the Market With a Bang

Why Celgene Sank to New Low Despite Q3 Earnings Beat

Short Sellers Chase Biotechs Higher

Short Sellers Hike Bets in Major Pharma

Jefferies Has Top Health Care Stocks to Buy as Sector Explodes

The Tale of 2 Biotechs: Aimmune vs DBV Tech

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Prospect Capital insiders are buying while yield hunters debate the safety

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Health and Healthcare Articles

All Health and Healthcare Articles

Why Neos Therapeutics Is Holding Out Against PDL BioPharma

What to Expect When Pfizer Reports Earnings

Why Novartis Is Moving to Acquire Advanced Accelerator Applications

Endo International Wins Big on Preliminary Results

Top Biopharma Events Coming by the End of 2017

Despite Poor Earnings Reaction, Analysts Still See Upside for Gilead

Why AbbVie Won Big in Q3, and Can Keep Winning

Merck Earnings Fall Short Despite Incredible Keytruda Sales

Gilead Earnings Bring Mixed Results

National Vision Enters the Market With a Bang

Why Celgene Sank to New Low Despite Q3 Earnings Beat

Short Sellers Chase Biotechs Higher

Short Sellers Hike Bets in Major Pharma

Jefferies Has Top Health Care Stocks to Buy as Sector Explodes

The Tale of 2 Biotechs: Aimmune vs DBV Tech

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Prospect Capital insiders are buying while yield hunters debate the safety

Featured Reads

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70